SCHEMBL4883157

SCHEMBL4883157

CCOC(=O)CCC(C)(C)C1OCCO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.41
LMNA P02545 2/20 0.41
TSHR P16473 1/20 0.41
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 1/20 0.38
RAB9A P51151 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GAA P10253 2/20 0.36
MGAM O43451 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
TRPA1 O75762 1/20 0.34
SMYD3 Q9H7B4 1/20 0.33
USP2 O75604 1/20 0.33
ALOX15 P16050 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
TNF P01375 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4886363 0.73 ALDH1A1 (0.34) POLBTSHRALDH1A1GAAMAPT
SCHEMBL12859411 0.72 CYP1A2 (0.47) POLBLMNATSHRALDH1A1CYP1A2
SCHEMBL4881514 0.72 ALDH1A1 (0.33) LMNATSHRALDH1A1RAB9AL3MBTL1
SCHEMBL14145112 0.72 CYP3A4 (0.40) LMNATSHRALDH1A1RAB9AL3MBTL1
SCHEMBL3368077 0.72 ALDH1A1 (0.52) POLBLMNATSHRALDH1A1CYP1A2
SCHEMBL9563856 0.71 CYP1A2 (0.45) POLBLMNATSHRALDH1A1CYP1A2
SCHEMBL1285433 0.71 CYP1A2 (0.45) POLBLMNATSHRALDH1A1CYP1A2
SCHEMBL1428085 0.70 CYP1A2 (0.48) POLBLMNATSHRALDH1A1CYP1A2
SCHEMBL6329652 0.69 GAA (0.52) POLBLMNATSHRALDH1A1CYP1A2
SCHEMBL4996608 0.69 TSHR (0.36) TSHRGAAMGAMSIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188448-A1 NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS BAYER SCHERING PHARMA AG (DE) 2008-08-07 US disclosed
US-20080188448-A1 NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS BAYER SCHERING PHARMA AG (DE) 2008-08-07 US disclosed
US-20080188448-A1 NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS BAYER SCHERING PHARMA AG (DE) 2008-08-07 US disclosed
WO-2008077647-A2 ALPHA- AMINO ALCOHOLS AS NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188448-A1 NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS PGR, PGRMC1, PGRMC2 POLB 3417/4885LMNA 1722/4885TSHR 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.